Sarah Meier
Impact in
-
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
-
- Polyomavirus and related diseases
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 4
- Immunotherapy and Immune Responses 2
- Atherosclerosis and Cardiovascular Diseases 1
- Oncology 4
- Cancer Treatment and Pharmacology 2
- CAR-T cell therapy research 1
- Co-authors
- Andreas Thiel (6 shared papers)Marco Frentsch (3 shared papers)Regina Stark (2 shared papers)Ulrik Stervbo (3 shared papers)Karsten Jürchott (3 shared papers)Axel Ronald Schulz (3 shared papers)Nina Babel (3 shared papers)Jürg Gertsch (2 shared papers)
- Journals
- CHIMIA International Journal for Chemistry (1 paper)ChemBioChem (1 paper)Cancer Immunology Immunotherapy (1 paper)Cytometry Part A (1 paper)Transplantation (1 paper)
- Partner nations
- GermanySwitzerlandChina
In The Last Decade
Sarah Meier
8 papers receiving 318 citations
Peers
Comparison fields: 5 of 59
- Immunology 178
- Oncology 126
- Aging 7
- Transplantation 8
- Infectious Diseases 43
Countries citing papers authored by Sarah Meier
This map shows the geographic impact of Sarah Meier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Meier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Meier more than expected).
Fields of papers citing papers by Sarah Meier
This network shows the impact of papers produced by Sarah Meier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Meier. The network helps show where Sarah Meier may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah Meier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 80 | |
| 2 | 2015 | 56 | |
| 3 | 2010 | 55 | |
| 4 | 2015 | 46 | |
| 5 | 2008 | 36 | |
| 6 | 2015 | 30 | |
| 7 | 2008 | 12 | |
| 8 | 2007 | 10 |
About Sarah Meier
Sarah Meier is a scholar working on Immunology, Oncology, Cell Biology, Molecular Biology and Insect Science, having authored 8 papers that have together received 325 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers), Microtubule and mitosis dynamics (2 papers), 14-3-3 protein interactions (2 papers), Cancer Treatment and Pharmacology (2 papers), Immunotherapy and Immune Responses (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Immunology (178 citations), Oncology (126 citations), Aging (7 citations), Transplantation (8 citations) and Infectious Diseases (43 citations). Sarah Meier has collaborated with scholars based in Germany, Switzerland and China. Frequent co-authors include Andreas Thiel, Marco Frentsch, Regina Stark, Ulrik Stervbo, Karsten Jürchott, Axel Ronald Schulz, Nina Babel, Jürg Gertsch, Sibel Durlanik and Michael R. Betts. Their work appears in journals such as CHIMIA International Journal for Chemistry, ChemBioChem, Cancer Immunology Immunotherapy, Cytometry Part A and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.